Company Description
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name.
In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories.
Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads.
It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors.
The company was incorporated in 1970 and is headquartered in Largo, Florida.
| Country | United States |
| Founded | 1970 |
| IPO Date | Jul 23, 1987 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 3,900 |
| CEO | Patrick Beyer |
Contact Details
Address: 11311 Concept Boulevard Largo, Florida 33773 United States | |
| Phone | 727 392 6464 |
| Website | conmed.com |
Stock Details
| Ticker Symbol | CNMD |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000816956 |
| CUSIP Number | 207410101 |
| ISIN Number | US2074101013 |
| Employer ID | 16-0977505 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Patrick J. Beyer | President, Chief Executive Officer and Director |
| Hollie K. Foust | Executive Vice President, General Counsel and Corporate Secretary |
| Peter K. Shagory | Executive Vice President of Strategy and Corporate Development |
| Todd W. Garner C.P.A. | Advisor |
| Brent Lalomia | Executive Vice President of Regulatory Affairs, Quality Assurance, Clinical Affairs, Commercial Operations and IT |
| Andrew Moller | Interim Principal Financial Officer, Principal Accounting Officer, Vice President and Corporate Controller |
| Josep Lluis Llorens | Executive Vice President Global Supply Chain Management and Operations |
| Richard Glaze | Chief Information Officer |
| Keith Seaton | Vice President of Compliance |
| John Ferrell | Executive Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 7, 2026 | ARS | Filing |
| Apr 7, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 7, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 26, 2026 | SCHEDULE 13G/A | Filing |
| Mar 13, 2026 | 8-K | Current Report |
| Feb 17, 2026 | 10-K | Annual Report |
| Jan 28, 2026 | 8-K | Current Report |
| Jan 12, 2026 | 8-K | Current Report |
| Jan 8, 2026 | 8-K | Current Report |
| Dec 5, 2025 | 8-K | Current Report |